Cargando…
Advances in developing small molecule SARS 3CL(pro) inhibitors as potential remedy for corona virus infection
Originated in China, coronavirus disease 2019 (COVID-19)- the highly contagious and fatal respiratory disease caused by SARS-CoV-2 has already infected more than 29 million people worldwide with a mortality rate of 3.15% (according to World Health Organization’s (WHO’s) report, September 2020) and t...
Autores principales: | Konwar, Manashjyoti, Sarma, Diganta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674993/ https://www.ncbi.nlm.nih.gov/pubmed/33230349 http://dx.doi.org/10.1016/j.tet.2020.131761 |
Ejemplares similares
-
Ethyl dibromofluoroacetate: a versatile reagent for the synthesis of fluorinated molecules
por: David, Emilie, et al.
Publicado: (2013) -
The evolution of Tamiflu synthesis, 20 years on: Advent of enabling technologies the last piece of the puzzle?
por: Sagandira, Cloudius R., et al.
Publicado: (2020) -
Recent advances in the chemistry of imine-based multicomponent reactions (MCRs)
por: Choudhury, Lokman H., et al.
Publicado: (2011) -
New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors
por: Regnier, Thomas, et al.
Publicado: (2009) -
Identification of Inhibitors of SARS-CoV-2
3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing
Screen
por: Kuzikov, Maria, et al.
Publicado: (2021)